Study Reference No. 22-1057

Study Type Demographic Gender Age Location Compensation
Investigational Oral Medicated Study Healthy volunteers Males and Females 18 - 55 years old Saint Petersburg FL $1,375.00
Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)] capsule is bioequivalent (where the active test study drug is absorbed into the body at the same rate and amount as an already approved drug) to a currently marketed capsule, as well as to monitor the safety of the study participants.

Study Schedule

General Screening


Medical Screening

Tue, Apr 05, Wed, Apr 06 and Fri, Apr 09

Study Visit(s)

Group 3 / Period I
Check-in: Thu, Apr 14, 2022
Check-out: Sat, Apr 16, 2022
Ambulatory 1: Sat, Apr 16, 2022
Ambulatory 2: Sun, Apr 17, 2022

Group 3 / Period II
Check-in: Thu, Apr 21, 2022
Check-out: Sat, Apr 23, 2022
Ambulatory 1:Sat, Apr 23, 2022
Ambulatory 2: Sun, Apr 24, 2022

Follow-Up Visit(s)


Other Notes

General good health and non-smoker

Study requires overnight stays